Medopia Co., Ltd. (Medopia) is a corporation located at 1-13-1 Tsukiji, Chuo-ku, Tokyo, established on December 9, 2004 and headed by Representative Director Yo Iwami (corporate number: 8011001073431). The last registration update was on September 13, 2024, and the absorption-type merger was carried out.
Financial results for the fiscal year ending September 2023 (sales: 14.54 billion yen, net income: 617 million yen) are posted. Career Change Conference has been rated 3.3/5.0 by employees and former employees on various review sites.
There is no legal violation/disposition/black information posted.
Company Profile
| Corporate number | 8011001073431 |
|---|---|
| Corporate name | Medopia Co., Ltd. |
| Furigana | Medopia |
| Address/Map | 〒104-0045 1-13-1 Tsukiji, Chuo-ku, Tokyo |
| Stock code | 6095 |
| President/Representative | Representative Director, President and CEO Yo Iwami (Doctor, MD) Director, Executive Officer, Vice President and COO Naoki Goto, Director and Executive Officer, CFO Toshio Hirabayashi, Director and Executive Officer Yoshihiko Tenbo, Outside Director Masatoshi Kawana (Doctor, MD) Outside Director Masayuki Shimura, Outside Director Mayuko Seto, Full-time Audit & Supervisory Board Member Shunichi Sueyoshi, Outside Audit & Supervisory Board Member Takashi Hayama, Outside Audit & Supervisory Board Member Hiroyasu Sato, Executive Officer, CHRO Takuma Tsuzuki, Executive Officer Masashi |
| URL | https://medpeer.co.jp/ |
| telephone number | Phone number: 03-4405-4905 Fax number: 03-6447-7962 |
| Establishment | December 9, 2004 |
| Industry | Medical/welfare |
| Corporate number designation date | 2015/10/05 |
| Last registration update date | 2024/09/13 |
Press release & advertisement from Medopia Co., Ltd.
Medopia Co., Ltd. financial history (million yen)
| year | quarter | Submission date | Sales | Operating profit | Ordinary profit | net income | comprehensive income |
|---|---|---|---|---|---|---|---|
Individual for September 2015 | 1Q results | 2015/02/12 | 340 | 126 | 126 | 70 | – |
| 2Q results | 2015/05/15 | 582 | 109 | 109 | 56 | – | |
| 3Q results | 2015/08/12 | 818 | 120 | 119 | 62 | – | |
| Full year forecast | 2014/11/13 | 1,450 | 300 | 300 | 167 | – | |
| Full year revision | 2015/08/12 | 1,030 | 120 | 119 | 62 | – | |
| Full-year results | 2015/11/11 | 1,039 | 136 | 135 | 70 | – | |
September 2016 /piece | 1Q results | 2016/02/10 | 293 | 53 | 54 | 34 | – |
| 2Q results | 2016/05/13 | 497 | 41 | 42 | 24 | – | |
| 3Q results | 2016/08/10 | 696 | 22 | 23 | 12 | – | |
| Full year revision | 2016/10/13 | 973 | 6 | 49 | 25 | – | |
| Full-year results | 2016/11/10 | 973 | 57 | 51 | 23 | 23 | |
Consolidated for September 2017 | 1Q results | 2017/02/10 | 361 | 24 | 21 | 6 | 6 |
| 2Q results | 2017/05/08 | 710 | 29 | 23 | -8 | -8 | |
| 3Q results | 2017/08/07 | 1,073 | 15 | 4 | -39 | -39 | |
| Full year forecast | 2016/11/10 | 2,150 | 100 | 80 | 25 | – | |
| Full year revision | 2017/10/12 | 1,558 | 103 | 86 | -280 | – | |
| Full-year results | 2017/11/06 | 1,559 | 82 | 65 | -363 | -363 | |
Consolidated for September 2018 | 1Q results | 2018/02/14 | 547 | 92 | 89 | 50 | 50 |
| 2Q results | 2018/05/07 | 1,072 | 184 | 202 | 101 | 101 | |
| 3Q results | 2018/08/13 | 1,604 | 294 | 305 | 167 | 167 | |
| Full year forecast | 2017/11/06 | 2,245 | 245 | 225 | 120 | – | |
| Full year revision | 2018/08/13 | 2,245 | 380 | 380 | 220 | – | |
| Full-year results | 2018/11/14 | 2,199 | 367 | 379 | 206 | 211 | |
Consolidated for September 2019 | 1Q results | 2019/02/13 | 762 | 174 | 176 | 127 | 128 |
| 2Q results | 2019/05/10 | 1,545 | 330 | 317 | 225 | 233 | |
| 3Q results | 2019/08/14 | 2,247 | 381 | 367 | 253 | 264 | |
| Full year forecast | 2018/11/14 | 3,200 | 540 | 520 | 270 | – | |
| Full year revision | 2019/08/14 | 3,200 | 540 | 520 | 310 | – | |
| Full-year results | 2019/11/13 | 3,045 | 558 | 554 | 394 | 428 | |
Consolidated for September 2020 | 1Q results | 2020/02/13 | 941 | 183 | 206 | 151 | 154 |
| 2Q results | 2020/05/13 | 2,311 | 484 | 508 | 341 | 367 | |
| 3Q results | 2020/08/13 | 3,659 | 733 | 757 | 485 | 540 | |
| Full year forecast | 2019/11/13 | 4,300 | 800 | 765 | 500 | – | |
| Full year revision | 2020/02/13 | 5,200 | 820 | 800 | 520 | – | |
| Full year revision | 2020/08/13 | 5,250 | 1,070 | 1,070 | 650 | – | |
| Full-year results | 2020/11/12 | 5,311 | 1,104 | 1,130 | 725 | 796 | |
Consolidated for September 2021 | 1Q results | 2021/02/15 | 1,938 | 626 | 637 | 437 | 432 |
| 2Q results | 2021/05/13 | 3,804 | 1,112 | 1,131 | 770 | 785 | |
| 3Q results | 2021/08/12 | 5,503 | 1,375 | 1,395 | 943 | 968 | |
| Full year forecast | 2020/11/12 | 7,450 | 1,610 | 1,610 | 1,070 | – | |
| Full year revision | 2021/08/12 | 7,450 | 1,800 | 1,830 | 1,230 | – | |
| Full-year results | 2021/11/11 | 7,435 | 1,783 | 1,812 | 1,293 | 1,331 | |
Consolidated for September 2022 | 1Q results | 2022/02/14 | 2,351 | 549 | 559 | 370 | 381 |
| 2Q results | 2022/05/12 | 4,440 | 866 | 889 | 598 | 613 | |
| 3Q results | 2022/08/09 | 6,443 | 907 | 943 | 654 | 647 | |
| Full year forecast | 2021/11/11 | 10,500 | 2,500 | 2,520 | 1,770 | – | |
| Full year revision | 2022/08/09 | 8,400 | 1,000 | 1,050 | 740 | – | |
| Full-year results | 2022/11/14 | 8,452 | 1,063 | 1,113 | 812 | 810 | |
Consolidated for September 2023 | 1Q results | 2023/02/13 | 3,686 | 467 | 474 | 270 | 267 |
| 2Q results | 2023/05/11 | 7,129 | 716 | 735 | 380 | 389 | |
| 3Q results | 2023/08/09 | 10,682 | 824 | 853 | 408 | 413 | |
| Full year forecast | 2022/11/14 | 14,000 | 1,500 | 1,530 | 850 | – | |
| Full-year results | 2023/11/13 | 14,540 | 1,119 | 1,164 | 617 | 637 | |
Consolidated for September 2024 | 1Q results | 2024/02/13 | 4,152 | 496 | 485 | 289 | 292 |
| 2Q results | 2024/05/13 | 7,850 | 835 | 831 | 199 | 212 | |
| 3Q results | 2024/08/14 | 11,445 | 1,028 | 1,029 | 429 | 448 | |
| Full year forecast | 2023/11/13 | 14,600 | 1,000 | 1,030 | 551 | – | |
| Full year revision | 2024/08/14 | 14,600 | 1,150 | 1,100 | 1,350 | – | |
| year | quarter | Submission date | Sales | Operating profit | Ordinary profit | net income | comprehensive income |
![Medicinal hair growth agent [hair tonic glow gel]](https://companydata.tsujigawa.com/wp-content/uploads/2024/07/hair-tonic-glow-gel-pr-01-150x150.jpg)
